Curatis AG

Curatis is a specialty pharmaceutical company based in Switzerland.

“We focus on the acquisition, development and commercialisation of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases.

Curatis is engaged in two business areas:

Development business

Distribution business Europe, Switzerland

We are seeking to partner our late stage phase III biological asset corticorelin for the treatment of peritumoral brain edema.

We are seeking Rx products to be marketed in Europe and Switzerland


Address

Liestal
Switzerland
Loading